14-10-2021, 10:30 AM
In the United States, the FDA approved at the end of September to apply a third injection of the aforementioned vaccine to older adults and vulnerable people, because clinical studies showed that the biological loses effectiveness four months after the second dose.
This group includes those over 65 years of age, adults with diseases such as diabetes or obesity and workers with a higher risk of contagion, such as health workers , teachers or employees of food stores, as long as they have previously received the complete guideline of Pfizer.
https://www.elfinanciero.com.mx/salud/20...r-y-ahora/
Meanwhile, Mexico has received 87 million 936 thousand 295 doses of Pfizer-BioNTech, AstraZeneca, Sinovac, Gamaleya National Research Center for Epidemiology and Microbiology, CanSino Biologics, Johnson & Johnson and Moderna.
Likewise, in Mexican territory, the Drugmex laboratory has packaged 8 million 933 thousand 650 doses of CanSino Biologics, and the Liomont laboratory 27 million 649 thousand 100 biologicals from AstraZeneca, which makes a total of 36 million 582 thousand 750 vaccines packaged in the country .
This group includes those over 65 years of age, adults with diseases such as diabetes or obesity and workers with a higher risk of contagion, such as health workers , teachers or employees of food stores, as long as they have previously received the complete guideline of Pfizer.
https://www.elfinanciero.com.mx/salud/20...r-y-ahora/
Meanwhile, Mexico has received 87 million 936 thousand 295 doses of Pfizer-BioNTech, AstraZeneca, Sinovac, Gamaleya National Research Center for Epidemiology and Microbiology, CanSino Biologics, Johnson & Johnson and Moderna.
Likewise, in Mexican territory, the Drugmex laboratory has packaged 8 million 933 thousand 650 doses of CanSino Biologics, and the Liomont laboratory 27 million 649 thousand 100 biologicals from AstraZeneca, which makes a total of 36 million 582 thousand 750 vaccines packaged in the country .